BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 8491046)

  • 1. Lupus membranous nephropathy: long-term outcome.
    Pasquali S; Banfi G; Zucchelli A; Moroni G; Ponticelli C; Zucchelli P
    Clin Nephrol; 1993 Apr; 39(4):175-82. PubMed ID: 8491046
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiphospholipid syndrome nephropathy in patients with systemic lupus erythematosus and antiphospholipid antibodies: prevalence, clinical associations, and long-term outcome.
    Tektonidou MG; Sotsiou F; Nakopoulou L; Vlachoyiannopoulos PG; Moutsopoulos HM
    Arthritis Rheum; 2004 Aug; 50(8):2569-79. PubMed ID: 15334471
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation among WHO classes, histomorphologic patterns of glomerulonephritis and glomerular immune deposits in SLE.
    Ferluga D; Jerse M; Vizjak A; Hvala A; Rozman B; Kos-Golja M; Bren AF
    Wien Klin Wochenschr; 2000 Aug; 112(15-16):692-701. PubMed ID: 11020959
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The prognosis of biopsy-proven lupus nephritis in chinese patients: long term follow-up of 86 cases.
    Shen K; Yu Y; Tang Z; Liu Z; Li L
    Chin Med J (Engl); 1997 Jul; 110(7):502-7. PubMed ID: 9594205
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical, biochemical and pathological predictors of poor response to intravenous cyclophosphamide in patients with proliferative lupus nephritis.
    Conlon PJ; Fischer CA; Levesque MC; Smith SR; St Clair EW; Allen NB; Fleming JA; Howell DN
    Clin Nephrol; 1996 Sep; 46(3):170-5. PubMed ID: 8879851
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Class V lupus nephritis: a clinicopathologic study in 152 patients.
    Chen Q; Liu Z; Hu W; Chen H; Zeng C; Li L
    J Nephrol; 2003; 16(1):126-32. PubMed ID: 12653107
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical course and prognostic factors in lupus nephropathy].
    Gamba G; Quintanilla L; del Bosque MD; Chew-Wong A; Correa-Rotter R
    Rev Invest Clin; 2000; 52(4):397-405. PubMed ID: 11061101
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Membranous nephropathy in systemic lupus erythematosus: long-term outcome and prognostic factors of 103 patients.
    Moroni G; Quaglini S; Gravellone L; Gallelli B; Leoni A; Messa P; Sinico RA
    Semin Arthritis Rheum; 2012 Apr; 41(5):642-51. PubMed ID: 22285127
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Renal graft survival in patients with systemic lupus erythematosus].
    Chew-Wong A; Soltero L; Diná E; Alvarez-Sandoval E; Alberú J; Gamba G; Correa-Rotter R
    Rev Invest Clin; 2002; 54(1):21-8. PubMed ID: 11995403
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Lupus nephritis: retrospective analysis of the course of the disease].
    Djukanović L; Pavlović S; Blagojević R; Dimitrijević J; Stojsic T; Ratković M; Kazić K; Lezaić V; Naumović R
    Srp Arh Celok Lek; 2002 Aug; 130 Suppl 3():26-31. PubMed ID: 12583310
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lupus membranous glomerulonephritis: different prognostic subgroups obscured by imprecise histologic classifications.
    Adler SG; Johnson K; Louie JS; Liebling MR; Cohen AH
    Mod Pathol; 1990 Mar; 3(2):186-91. PubMed ID: 2326250
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Significance of antiphospholipid antibodies in lupus nephritis.
    Natejumnong C; Ruangkanchanasetr P; Aimpun P; Supaporn T
    J Med Assoc Thai; 2006 Aug; 89 Suppl 2():S121-8. PubMed ID: 17044463
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Comparison of various cyclophosphamide treatment regimens on the course and outcome of lupus nephritis ].
    Petrović R; Stojanović R; Novicić-Sasić D; Dimitrijević J; Pavlović S; Stojković D; Palić-Obradović D; Stevanović G; Prodanović S
    Srp Arh Celok Lek; 2002 Aug; 130 Suppl 3():19-25. PubMed ID: 12583309
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systemic lupus with nephritis: a long-term study.
    Cameron JS; Turner DR; Ogg CS; Williams DG; Lessof MH; Chantler C; Leibowitz S
    Q J Med; 1979 Jan; 48(189):1-24. PubMed ID: 482585
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Long-term follow-up on the treatment of diffuse proliferative glomerulonephritis in patients with systemic lupus erythematosus].
    Golan E; Weintal I; Bernheim J; Ben-Chetrit S; Bernheim J
    Harefuah; 2002 Apr; 141(4):324-8, 412. PubMed ID: 12017882
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Longterm followup of childhood lupus nephritis.
    Hagelberg S; Lee Y; Bargman J; Mah G; Schneider R; Laskin C; Eddy A; Gladman D; Urowitz M; Hebert D; Silverman E
    J Rheumatol; 2002 Dec; 29(12):2635-42. PubMed ID: 12465165
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determinants of renal functional outcome in lupus nephritis: a single centre retrospective study.
    Chrysochou C; Randhawa H; Reeve R; Waldek S; Wood GN; O'Donoghue DJ; Kalra PA
    QJM; 2008 Apr; 101(4):313-6. PubMed ID: 18270227
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The long-term outcome of 93 patients with proliferative lupus nephritis.
    Moroni G; Quaglini S; Gallelli B; Banfi G; Messa P; Ponticelli C
    Nephrol Dial Transplant; 2007 Sep; 22(9):2531-9. PubMed ID: 17510096
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Membranous glomerulonephritis. Experience at the Instituto Nacional de la Nutrición Salvador Zubirán].
    Correa-Rotter R; Gamba G; Ochoa C; Onuma L; Reyes E; Tamayo JA; Peña JC
    Rev Invest Clin; 1990; 42(2):114-9. PubMed ID: 2267443
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictors and outcome of renal flares after successful cyclophosphamide treatment for diffuse proliferative lupus glomerulonephritis.
    Mok CC; Ying KY; Tang S; Leung CY; Lee KW; Ng WL; Wong RW; Lau CS
    Arthritis Rheum; 2004 Aug; 50(8):2559-68. PubMed ID: 15334470
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.